UnitedHealthcare
Kesimpta (ofatumumab)
Drugs for the Nervous System : Drugs for Multiple Sclerosis
  • Multiple Sclerosis (MS):
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Patients Cardiac Medical History Required: No
    Concomitant use of other MS medication: No

    Secondary Progressive Multiple Sclerosis:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

  • Prior Authorization: Documented Diagnosis: Yes
    Duration: 12 Month(s)